Venture&Growth
Location
Barcelona, Spain 
Venture&Growth
All Portfolio items
See full Venture&Growth portfolio
Splice Bio is a biotech company based on intein technologies developed in the Muir Lab at Princeton University. They are working with their proprietary platform to address key limitations of current gene therapy approaches to treat patients in need. The company is building a product pipeline of gene therapies targeting inherited retinal diseases and other severe genetic diseases for which there is no cure.
More Splice Bio news
Gilde Healthcare company SpliceBio enters $216 million Gene Therapy collaboration with Spark Therapeutics
Gilde Healthcare invests in Eur 50M series A round of Spanish Gene Therapy company SpliceBio
Spire Health
US-based Healthtech company providing remote patient monitoring solutions for COPD patients.
Lumeon
UK-based HealthTech company offering care pathway solutions
Nalu Medical
Nalu Medical is a US medical device company that develops and commercializes neuromodulation systems for...
